Productivity in pharmaceutical–biotechnology R&D: the role of experience and alliances
- 25 January 2005
- journal article
- Published by Elsevier in Journal of Health Economics
- Vol. 24 (2) , 317-339
- https://doi.org/10.1016/j.jhealeco.2004.09.006
Abstract
No abstract availableKeywords
All Related Versions
This publication has 15 references indexed in Scilit:
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Risks in new drug development: Approval success rates for investigational drugsClinical Pharmacology & Therapeutics, 2001
- New Drug Innovation and Pharmaceutical Industry Structure: Trends in the Output of Pharmaceutical FirmsDrug Information Journal, 2000
- The Control of Technology Alliances: An Empirical Analysis of the Biotechnology IndustryJournal of Industrial Economics, 1998
- R&D Performance, Collaborative Arrangements and the Market for Know-How: A Test of the "Lemons" Hypothesis in BiotechnologySSRN Electronic Journal, 1997
- Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in BiotechnologyAdministrative Science Quarterly, 1996
- Do Important Drugs Reach the Market Sooner?The RAND Journal of Economics, 1994
- Cost of innovation in the pharmaceutical industryJournal of Health Economics, 1991
- Joint ventures: Theoretical and empirical perspectivesStrategic Management Journal, 1988
- Corporate financing and investment decisions when firms have information that investors do not haveJournal of Financial Economics, 1984